Panagiotis Gklinos

Years Active: 2020-2024
Publications (10 Years): 7

KAT General Hospital

Sapienza University of Rome (MSC)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

KAT General Hospital

Greece

Resident Neurologist :: Department of Neurology

Education History

Sapienza University of Rome

Italy

MSC

National and Kapodistrian University of Athens - Faculty of Medicine

Greece

PHD

Publications

Panagiotis Gklinos, Ruth Dobson
Myelin Oligodendrocyte Glycoprotein-Antibody Associated Disease: An Updated Review of the Clinical Spectrum, Pathogenetic Mechanisms and Therapeutic Management. Antibodies (Basel, Switzerland) 13 (2) (2024)
Panagiotis Gklinos, Ruth Dobson
Myelin Oligodendrocyte Glycoprotein-Antibody Associated Disease: An Updated Review of the Clinical Spectrum, Pathogenetic Mechanisms and Therapeutic Management. Antibodies (Basel, Switzerland) 13 (2) (2024)
Panagiotis Gklinos, Ruth Dobson
Monoclonal Antibodies in Pregnancy and Breastfeeding in Patients with Multiple Sclerosis: A Review and an Updated Clinical Guide. Pharmaceuticals (Basel, Switzerland) 16 (5) (2023)
Panagiotis Gklinos, Miranta Papadopoulou, Vid Stanulovic, Dimos-Dimitrios D Mitsikostas, Dimitrios Papadopoulos
Monoclonal Antibodies as Neurological Therapeutics. Pharmaceuticals (Basel, Switzerland) 14 (2) (2021)
Panagiotis Gklinos, Dimos D Mitsikostas
The Role of Galcanezumab in Migraine Prevention: Existing Data and Future Directions. Pharmaceuticals (Basel, Switzerland) 14 (3) (2021)
Panagiotis Gklinos
Neurological manifestations of COVID-19: a review of what we know so far. Journal of neurology 267 (9) (2020)
Panagiotis Gklinos, Dimos D Mitsikostas
Galcanezumab in migraine prevention: a systematic review and meta-analysis of randomized controlled trials. Therapeutic advances in neurological disorders 13 (2020)

Panagiotis Gklinos.css-eqlu8i{font-size:small;padding-left:4px;}